In detail, gut microbiota-derived glycodeoxycholic acid and tauroursodeoxycholic acid promote the production of interleukin-22 by intestinal group 3 innate lymphoid cells and subsequently limit PCOS development. The gene discussed is IL22; the disease is polycystic ovary syndrome.